Grant: Master's Award: Canada Graduate Scholarships
Université Laval
$17,500.00
Understanding the transport of pathogenic proteins into the central nervous system for the Huntington's disease
EF 2018-19
Résumé
Recent work conducted in Dr. Cicchetti’s laboratory has demonstrated that healthy tissue transplants implanted into the brains of patients with Huntington's disease expressed, after several years, pathological signs of the disease, such as the mutant huntingtin protein (mHtt) - the genetic product of the disease. Her research team also demonstrated that the permeability of the blood-brain barrier - a barrier that allows blood vessels to filter toxins from the periphery to prevent contaminating the brain – presented certain anomalies in these patients. Taken together, these observations suggest that mHtt is capable of being transported from a diseased to a healthy cell and/or possibly via blood vessels that were made more permeable by the disease. A better understanding of the transmission mechanisms of mHtt to the central nervous system could radically change how we treat Huntington's disease. My master's thesis focuses on studying the impacts of certain transporters of the blood-brain barrier, such as LRP-1, and its effect in facilitating or inhibiting the transport of mHtt into the central nervous system. We will use a pharmacological approach to influence the transport of mHtt by LRP-1 in mice models of the disease and evaluate behaviour to determine if the treatment results in beneficial effects; both the improvement of behavioural abnormalities as well as pathological features.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
411192
Name
Dufour Josiane
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the transport of pathogenic proteins into the central nervous system for the Huntington's disease
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Model; Antibodies; Blood-Brain Barrier; Huntingtin; Huntington'S Disease; Lrp-1
Abstract
Recent work conducted in Dr. Cicchetti’s laboratory has demonstrated that healthy tissue transplants implanted into the brains of patients with Huntington's disease expressed, after several years, pathological signs of the disease, such as the mutant huntingtin protein (mHtt) - the genetic product of the disease. Her research team also demonstrated that the permeability of the blood-brain barrier - a barrier that allows blood vessels to filter toxins from the periphery to prevent contaminating the brain – presented certain anomalies in these patients. Taken together, these observations suggest that mHtt is capable of being transported from a diseased to a healthy cell and/or possibly via blood vessels that were made more permeable by the disease. A better understanding of the transmission mechanisms of mHtt to the central nervous system could radically change how we treat Huntington's disease. My master's thesis focuses on studying the impacts of certain transporters of the blood-brain barrier, such as LRP-1, and its effect in facilitating or inhibiting the transport of mHtt into the central nervous system. We will use a pharmacological approach to influence the transport of mHtt by LRP-1 in mice models of the disease and evaluate behaviour to determine if the treatment results in beneficial effects; both the improvement of behavioural abnormalities as well as pathological features.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dufour, Josiane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~